Entourage - CCO, Joseph Mele
CCO, Joseph Mele
Source: Entourage Health Corp.

Entourage Health Corp. (ENTG) has announced a line of new recreational cannabis products for its Color Cannabis and Saturday Cannabis lines.

The new, limited-edition products will hit the market first in Ontario, followed closely by Alberta and British Columbia, then the rest of Canada throughout next month.

The Color line debuted an advent calendar with a collection of pre-rolls in various cultivars, including an exclusive holiday blend. Also new with this line are mango haze, and Pedro’s Sweet Sativa flavoured soft chews as well as Pedro’s Sweet Sativa Live Sugar infused pre-rolls

Following the launch in Western Canada, Entourage’s cannabis beverage, TeaPot Good Day Iced Tea, will debut in Ontario in early November.

Source: Entourage Health Corp./Instagram

Joseph Mele, Chief Commercial Officer of Entourage, commented,

“Entourage continues to find new ways to delight the market by first listening to consumer feedback and working with our integrated commercial team to build and launch new products aligned with consumer preferences.”

In addition, the company also released more products to its Saturday line, including green apple, cranberry sauce, and pomegranate-flavoured vapes.

More product releases are scheduled for later this year, such as the Saturday Cannabis Tropical & Twisted Ready-to-Roll CBD flower and the Color Cannabis Mango Haze PAX Pod.

Entourage Health Corp. (ENTG) is up 12.50 per cent and is trading at $0.04 per share as of 11:44 a.m. ET.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.